Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus. Evidence Report/Technology Assessment No. 84

摘要

While testing for glycemic control and urine albumin are widely recommended for persons with Types 1 and 2 diabetes mellitus there has not been a systematic assembly of the literature to assess the risk relation between tests assessing long-term glycemic control or tests assessing the presence of microalbuminuria to future cardiovascular, peripheral vascular, renal, and neurological outcomes (all of which represent end-organ effects of long-term diabetes). This report, commissioned by the American Association of Clinical Chemistry, systematically reviews the literature identifying the risk relation between testing for glycemic control and urine albumin with these important chemical outcomes.